HIGH-THROUGHPUT T-CELL RECEPTOR GENE REPERTOIRE PROFILING IN CHRONIC LYMPHOCYTIC LEUKEMIA SUBSET #4: FURTHER EVIDENCE OF ANTIGENIC STIMULATION
Author(s): ,
Anna Vardi
Affiliations:
Institute of Applied Biosciences,CERTH,Thessaloniki,Greece
,
Evangelia Stalika
Affiliations:
Institute of Applied Biosciences,CERTH,Thessaloniki,Greece
,
Athanasios Gkoufas
Affiliations:
Institute of Applied Biosciences,CERTH,Thessaloniki,Greece;Laboratory of Medical Informatics,Medical School, Aristotle University of Thessaloniki,Thessaloniki,Greece
,
Maria Karipidou
Affiliations:
Hematology Department & HCT Unit,G.Papanikolaou Hospital,Thessaloniki,Greece
,
Christos Maramis
Affiliations:
Laboratory of Medical Informatics,Medical School, Aristotle University of Thessaloniki,Thessaloniki,Greece;Institute of Applied Biosciences,CERTH,Thessaloniki,Greece
,
Vassileios Bikos
Affiliations:
Central European Institute of Technology,Masaryk University and University Hospital Brno,Brno,Czech Republic
,
Sarka Pospisilova
Affiliations:
Central European Institute of Technology,Masaryk University and University Hospital Brno,Brno,Czech Republic
,
Achilles Anagnostopoulos
Affiliations:
Hematology Department & HCT Unit,G.Papanikolaou Hospital,Thessaloniki,Greece
,
Nikolaos Maglaveras
Affiliations:
Laboratory of Medical Informatics,Medical School, Aristotle University of Thessaloniki,Thessaloniki,Greece;Institute of Applied Biosciences,CERTH,Thessaloniki,Greece
,
Ioanna Chouvarda
Affiliations:
Laboratory of Medical Informatics,Medical School, Aristotle University of Thessaloniki,Thessaloniki,Greece;Institute of Applied Biosciences,CERTH,Thessaloniki,Greece
,
Kostas Stamatopoulos
Affiliations:
Institute of Applied Biosciences,CERTH,Thessaloniki,Greece;Department of Immunology, Genetics and Pathology, Rudbeck Laboratory,Uppsala University,Uppsala,Sweden
Anastasia Hadzidimitriou
Affiliations:
Institute of Applied Biosciences,CERTH,Thessaloniki,Greece;Department of Immunology, Genetics and Pathology, Rudbeck Laboratory,Uppsala University,Uppsala,Sweden
EHA Learning Center. Vardi A. Jun 12, 2015; 103209
Disclosure(s): G.Papanikolaou Hospital
Hematology Department & HCT Unit
Anna Vardi
Anna Vardi

Access to EHA Members only content is an EHA membership benefit. Click here to join EHA or renew your membership here.


Abstract
Discussion Forum (0)
Rate & Comment (0)
Abstract: S123

Type: Oral Presentation

Presentation during EHA20: From 12.06.2015 12:00 to 12.06.2015 12:15

Location: Room A8

Background

Chronic lymphocytic leukemia (CLL) is characterized by a remarkably restricted immunoglobulin (IG) gene repertoire, mainly attributable to the existence of subsets of patients with stereotyped B-cell receptor (BcR) IGs strongly implying clonal selection by a restricted set of antigens. Our preliminary high-throughput, next-generation sequencing studies of the T-cell receptor beta chain (TRB) gene repertoire in CLL cases from various subsets indicated repertoire skewing, pointing to antigenic selection of the T cells as well, which is relevant in view of the bidirectional CLL-T cell interactions.



Aims

We performed in-depth profiling of the TRB gene repertoire in CLL subset #4 which became our focus for the following reasons: (i) it is the most indolent subgroup of CLL patients identified thus far; (ii) previous studies have strongly supported ongoing antigenic stimulation attested by the intraclonal diversification of the clonotypic IG.



Methods

We studied 11 untreated CLL subset #4 cases and a healthy control. RNA was isolated from peripheral blood mononuclear cells (n=12) or purified CD4+ and CD8+ T cells (n=2 CLL cases). Two patients were studied overtime. TRBV-TRBD-TRBJ gene rearrangements were amplified on cDNA according to the BIOMED2 protocol and subjected to paired-end NGS (MiSeq Illumina Platform). The experimental design allowed sequencing of the complementarity determining region 3 (CDR3) twice/read, so as to increase the accuracy of results. Computational processing of raw data was performed using a purpose-built algorithm and a bioinformatics platform was developed for IMGT/HighV-QUEST metadata clustering and analysis.



Results

Overall, 12,261,280 TRBV-TRBD-TRBJ reads were produced (median 397,035 reads/sample, median Q-score 38.4). Poor quality, incomplete, out-of-frame and unproductive rearrangements were filtered out. For repertoire analyses, clonotypes (i.e. TRB rearrangements with identical TRBV gene usage and amino acid CDR3 sequence) rather than single rearrangement reads were considered (median 77020 distinct clonotypes/sample, 54733 singletons versus 22287 expanded). Among the 53 functional TRBV genes identified, 5 predominated: TRBV12-3/12-4 (9.9%), TRBV29-1 (8.6%), TRBV19 (7.5%), TRBV5-1 (5.5%), and TRBV6-5 (4.9%), collectively accounting for 36.4% of the TRBV repertoire. Comparison of the TRBV gene repertoire of CD8+ vs CD4+ cells showed that TRBV19 was overrepresented in the CD4+ compartment (9.4% versus 6.9%, p<0.001). The TRB repertoire was significantly more oligoclonal in CLL compared to the healthy control (median frequency of the predominant clonotype: 3.6% versus 0.47%, respectively, p<0.001), and this skewing stemmed mainly from the CD8+ rather than the CD4+ compartment (median frequency of the predominant clonotype 10.7% versus 1.0%, respectively, p<0.001). Cluster analysis of all CLL cases identified 37303 different clonotypes (excluding singletons) shared by different patients and not present in the healthy control. The longitudinal analysis of 2 cases showed contrasting results, with 14.6% of all expanded clonotypes persisting over time in one case, but only 0.06% in the other. In the former case, 5 of the persisting clonotypes ranked among the 10 most expanded within the patient's T cell repertoire, whereas in the latter case only minor clonotypes persisted.



Summary

Our study provides large-scale evidence of TR repertoire skewing and oligoclonality in CLL subset #4, strongly supporting antigenic selection. The nature of selecting antigens remains to be elucidated.



Keyword(s): TCR

Session topic: CLL - Biology: Interacting determinants of CLL ontogeny and evolution
Code of conduct/disclaimer available in General Terms & Conditions
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings